New Under-the-Tongue painkiller could speed up surgery recovery
NCT ID NCT07624006
First seen Jun 14, 2026 · Last updated Jun 23, 2026 · Updated 1 time
Summary
This study compares a new under-the-tongue painkiller (sublingual sufentanil) to standard morphine pills for managing pain after surgery. The goal is to see if the new drug helps patients recover their health faster. About 1150 adults having surgery will take part, receiving either the new drug or morphine as needed for up to three days after their operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sublingual sufentanil (Dzuveo)
What this could lead to
If it works, this could offer a faster-acting pain relief option after surgery, potentially improving recovery quality.
What could go wrong
This is a Phase 4 trial, so the drug is already approved. However, it may not prove significantly better than morphine, and side effects like nausea or dizziness are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.